Garner William J

CIK 00014072353 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001407235

Recent Transactions

32 trades

Expiration (Short)
InMed Pharmaceuticals Inc.$INM
Employee Stock Option (Expiration)
2022-01-24−24,242→ 16,122 total
Award
InMed Pharmaceuticals Inc.$INM
Employee Stock Option (Right to Buy)
2021-12-29+7,000→ 40,364 total
Award
InMed Pharmaceuticals Inc.$INM
Employee Stock Option (Right to Buy)
2020-12-16+7,000→ 7,000 total
Purchase
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2015-07-16$0.60/sh+16,666→ 2,415,207 total
Purchase
TuHURA Biosciences, Inc./NV$HURA
Warrant
2015-07-16$0.00/sh+16,666→ 16,666 total
Sale
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18$1.30/sh−10,000→ 30,000 total
Conversion
TuHURA Biosciences, Inc./NV$HURA
Exchangeable Shares
2014-03-18$0.01/sh−80,000→ 2,513,541 total
Conversion
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18+80,000→ 90,000 total
Sale
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18$1.30/sh−25,000→ 40,000 total
Conversion
TuHURA Biosciences, Inc./NV$HURA
Exchangeable Shares
2014-03-18−80,000→ 2,438,541 total
Sale
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18$1.30/sh−25,000→ 65,000 total
Sale
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18$1.30/sh−10,000→ 20,000 total
Sale
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2014-03-18$1.30/sh−10,000→ 10,000 total
Conversion
TuHURA Biosciences, Inc./NV$HURA
Warrants (Right to Buy)
2013-11-26−5,000→ 45,000 total
Conversion
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2013-11-26+5,000→ 10,000 total
Purchase
TuHURA Biosciences, Inc./NV$HURA
Common Stock
2013-09-20$1.00/sh+5,000→ 5,000 total
Award
TuHURA Biosciences, Inc./NV$HURA
Options (Right to Buy)
2013-08-16+120,000→ 120,000 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-13$0.09/sh+1,000→ 18,587,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-13$0.09/sh+1,000→ 18,586,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-11$0.09/sh+1,000→ 18,585,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-05$0.08/sh+5,000→ 18,584,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-02-25$0.10/sh+1,000→ 18,579,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-30$0.13/sh+10,000→ 18,578,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-30$0.14/sh+7,800→ 18,568,340 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-29$0.15/sh+16,000→ 18,560,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-27$0.10/sh+5,000→ 18,539,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-27$0.14/sh+5,000→ 18,544,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-26$0.17/sh+5,000→ 18,534,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-21$0.04/sh+48,000→ 18,529,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-21$0.10/sh+43,000→ 18,529,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-21$0.09/sh+5,000→ 18,486,540 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-20$0.04/sh+5,000→ 18,481,540 total

Companies

Recent Filings

Address

C/O URIGEN PHARMACEUTICALS, INC. 27 MAIDEN LANE

SAN FRANCISCO, CA, 94108

View on SEC.gov